cytarabine has been researched along with Cancer of Prostate in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Dimas, K; Eleutheriades, A; Foscolos, GB; Georgakopoulou, S; Khan, H; Kourafalos, VN; Mantelas, A; Mirjolet, JF; Moutsos, VI; Papanastasiou, I; Pondiki, S; Prassa, M; Riganas, S; Serin, G; Theodoropoulou, M; Tsotinis, A; Vamvakides, A; Zaniou, A | 1 |
| Pathania, S; Rawal, RK | 1 |
| Jeong, LS; Lee, SK; Song, J; Yu, J | 1 |
| Baur, M; Daum, L; Franke, K; Schlosshauer, B; Sievert, KD; Vaegler, M | 1 |
| Aldayel, AS; Konoplev, S; Medeiros, LJ; Rich, A; Sun, J; Yin, CC | 1 |
| Ando, K; Kawada, H; Murayama, H; Nakamura, N; Ogawa, Y; Ohmachi, K; Suzuki, R; Tsuboi, K | 1 |
| FUJIMOTO, H; HIASA, Y; HORIUCHI, N; KIMURA, S; MASUDA, K; MATSUSHITA, T; NAKAMURA, S; SHICHIJO, K; SHINOMIYA, S; TAKAHASHI, K; TAKEICHI, T; TAMAKI, Y; YAMANAKA, C | 1 |
| Adams, L; Day, JR; Dhani, NC; Emmenegger, U; Groskopf, J; Jongstra, J; Joshua, AM; Knox, JJ; Sridhar, SS; Tannock, IF | 1 |
| Gandhok, N; Sartor, O | 1 |
| Kiss, A; Kowalski, J; Melzig, MF | 1 |
| Bouscary, D; Dômont, J; Goldwasser, F; Martinez, V; Mir, O | 1 |
| Cheng, YC; Chu, CK; Gao, Z; Grove, KL; Guo, X; Liu, SH | 1 |
| Cheng, YC; Grove, KL | 1 |
| Kidd, P; Quien, ET; Saidi, P; Sandhaus, L; Strair, R; Wallach, B | 1 |
| Cattaneo-Pangrazzi, RM; Schott, H; Schwendener, RA | 1 |
| Cass, CE; Clarke, ML; Gourdeau, H; Jolivet, J; Lafrenière, RG; Lee, N; Mackey, JR; Mowles, D; Ouellet, F; Richard, A; Selner, M; Young, JD | 1 |
| Dostal, V; Fanta, D; Reiss-Gutfreund, RJ | 1 |
| Hashimura, T; Hida, S; Kanamaru, H; Nishimura, K; Nishio, Y; Oishi, K; Okada, K; Yamauchi, T; Yoshida, O; Yoshiki, T | 1 |
| Kanwal, G; Kim, RH; Li, MC | 1 |
4 review(s) available for cytarabine and Cancer of Prostate
| Article | Year |
|---|---|
Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.
Topics: Animals; Anti-Retroviral Agents; Antineoplastic Agents; HIV Infections; Humans; Male; Molecular Structure; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Pyrroles; Structure-Activity Relationship | 2018 |
Myelomastocytic leukemia with aberrant CD25 expression: case report and review of the literature.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Brain; Cerebral Hemorrhage; Cytarabine; Fatal Outcome; Humans; Hydroxamic Acids; Idarubicin; Interleukin-2 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Leukemic Infiltration; Male; Mast Cells; Middle Aged; Neoplasms, Second Primary; Neoplastic Stem Cells; Opportunistic Infections; Prostatectomy; Prostatic Neoplasms; Vorinostat | 2014 |
Primary extramedullary leukemia of the prostate: case report and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnostic Errors; Doxorubicin; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prostatectomy; Prostatic Neoplasms; Radioisotope Teletherapy; Remission Induction; Urinary Retention; Vincristine | 1996 |
[Herpes simplex virus (hsv-1 and hsv-2) infection: its clinical and oncogenic properties (author's transl)].
Topics: Amantadine; Animals; Antibody Formation; Antigen-Antibody Complex; BCG Vaccine; Cell Transformation, Neoplastic; Complement C3; Cytarabine; DNA, Viral; Female; Ganglia; Genital Diseases, Female; Genital Diseases, Male; Haplorhini; Herpes Labialis; Herpes Simplex; Herpesvirus 4, Human; Humans; Idoxuridine; Immunity, Cellular; Levamisole; Male; Proflavine; Prostatic Neoplasms; Rabbits; Uterine Cervical Neoplasms; Vidarabine; Viral Vaccines | 1977 |
1 trial(s) available for cytarabine and Cancer of Prostate
| Article | Year |
|---|---|
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biomarkers; Carrier Proteins; Castration; Cytarabine; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Prostatic Neoplasms; RNA, Messenger; Serine Endopeptidases; Taxoids; Trans-Activators; Transcriptional Regulator ERG; Trypsin Inhibitor, Kazal Pancreatic | 2012 |
14 other study(ies) available for cytarabine and Cancer of Prostate
| Article | Year |
|---|---|
New adamantane phenylalkylamines with σ-receptor binding affinity and anticancer activity, associated with putative antagonism of neuropathic pain.
Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Proliferation; Female; Humans; Male; Mice; Mice, SCID; Molecular Structure; Neuralgia; Ovarian Neoplasms; Pancreatic Neoplasms; Piperidines; Prostatic Neoplasms; Protein Binding; Receptors, sigma; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cytarabine; DNA Damage; DNA Repair; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Synthetic Lethal Mutations; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2021 |
Prostate carcinoma cell growth-inhibiting hydrogel supports axonal regeneration in vitro.
Topics: Aged, 80 and over; Animals; Antineoplastic Agents; Axons; Biocompatible Materials; Cell Adhesion; Cell Proliferation; Cross-Linking Reagents; Cytarabine; Drug Carriers; Fibroblasts; Ganglia, Spinal; Gelatin; Humans; Hydrogels; Male; Mice; Nerve Regeneration; Neurons; Prostatic Neoplasms; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Schwann Cells; Sciatic Nerve; Transglutaminases; Tumor Cells, Cultured | 2013 |
[Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease Progression; Dysuria; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Remission Induction; Sarcoma, Myeloid | 2008 |
Multiple hepatocellular carcinomas developed 15 months after commencement of chemotherapy for elderly acute myelogenous leukemia.
Topics: Aclarubicin; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cytarabine; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Hemochromatosis; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Neoplasms, Second Primary; Prostatic Neoplasms; Time Factors | 2009 |
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.
Topics: Adenocarcinoma; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Goserelin; Humans; Immunocompromised Host; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasms, Second Primary; Neutropenia; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostate-Specific Antigen; Prostatic Neoplasms; Recurrence; Sepsis; Tosyl Compounds; Vincristine | 2004 |
Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.
Topics: Cell Line, Tumor; Cell Proliferation; Cytarabine; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Induction; Epilobium; Humans; Hydrolyzable Tannins; Male; Medicine, Traditional; Neprilysin; Peptidyl-Dipeptidase A; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Water | 2006 |
Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
Topics: Androgens; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cytarabine; Humans; In Situ Hybridization; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Prostatic Neoplasms | 2007 |
Anticancer activity of beta-L-dioxolane-cytidine, a novel nucleoside analogue with the unnatural L configuration.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Colonic Neoplasms; Cytarabine; Cytosine; Dioxolanes; Drug Screening Assays, Antitumor; Humans; KB Cells; Leukemia P388; Liver Neoplasms; Male; Mice; Molecular Structure; Phosphorylation; Prostatic Neoplasms; Stereoisomerism; Tumor Cells, Cultured | 1995 |
Uptake and metabolism of the new anticancer compound beta-L-(-)-dioxolane-cytidine in human prostate carcinoma DU-145 cells.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Cell Line; Cytarabine; Cytosine; Dioxolanes; DNA, Neoplasm; Humans; Kinetics; Male; Prostatic Neoplasms; Tritium; Tumor Cells, Cultured | 1996 |
The novel heterodinucleoside dimer 5-FdU-NOAC is a potent cytotoxic drug and a p53-independent inducer of apoptosis in the androgen-independent human prostate cancer cell lines PC-3 and DU-145.
Topics: Androgens; Antimetabolites, Antineoplastic; Apoptosis; Biotransformation; Cell Cycle; Cell Division; Cytarabine; Dimerization; Dose-Response Relationship, Drug; Enzyme Inhibitors; Floxuridine; Fluorodeoxyuridylate; Humans; Hydrolysis; Male; Neoplasms, Hormone-Dependent; Phosphodiesterase I; Phosphoric Diester Hydrolases; Prodrugs; Prostatic Neoplasms; Thymidylate Synthase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
Topics: Amino Acid Sequence; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cytarabine; Cytidine Deaminase; Cytosine; Deoxycytidine; Deoxycytidine Kinase; Dioxolanes; Drug Resistance, Neoplasm; Gemcitabine; Humans; Leukemia; Male; Membrane Proteins; Molecular Sequence Data; Nucleoside Transport Proteins; Phosphorylation; Prostatic Neoplasms; Sequence Homology, Amino Acid; Sodium; Stereoisomerism; Tritium; Tumor Cells, Cultured; Uridine | 2001 |
[Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line; Cisplatin; Cytarabine; Etoposide; Fluorouracil; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Peplomycin; Prostatic Neoplasms; Testicular Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vinblastine; Vincristine | 1988 |
Prostatic tumor acid phosphatase production. Influence of antineoplastic agents.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Antineoplastic Agents; Aspartate Aminotransferases; Blood Glucose; Blood Urea Nitrogen; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Plicamycin; Prostatic Neoplasms; Thiotepa | 1973 |